Sickle Cell Crisis

Practical Management of Haemoglobinopathies

Volumn , Issue , 2007, Pages 63-71

  Okpala, Iheanyi E ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Aplastic crisis; Hyperbilirubinaemia; Sickle cell disease (SCD); Splenic hepatic sequestration crisis; Vaso occlusive crisis

Indexed keywords

EID: 84922367235     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988398.ch7     Document Type: Chapter

References (31)

1. Hedo CC, Aken'Ova AY, Okpala IE, Durojaiye AO, Salimonu LS. Acute phase reactants and the severity of homozygous sickle cell disease. J Intern Med 1993; 233: 467-70.
2. Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol 2002; 9: 101-6.
3. Addae SK, Konotey-Ahulu FID. Lack of diurnal variation in sodium, potassium and osmolal excretion in the sickle cell patient. Afr J Med Sci 1971; 2: 349-59.
4. Robieux IC, Kellner JD, Coppes MJ. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs continous infusion of morphine and placebo controlled study of oxygen inhalation. Pediatr Hematol Oncol 1992; 9: 317-26.
5. Zipursky A, Robieux IC, Brown EJ et al. Oxygen therapy in sickle cell disease. Am J Pediatr Hematol Oncol 1992; 14: 222-8.
6. Johnston RB Jr, Hewman SL, Struth AC. An abnormality of the alternative pathway of complement activation in sickle cell disease. N Engl J Med 1973; 288: 803-5.
7. Anyaegbu CC, Okpala IE, Aken'Ova AY, Salimonu LS. Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia. Acta Pathol Microbiol Scand 1999; 107: 699-702.
8. Anyaegbu CC, Okpala IE, Aken'Ova AY, Salimonu LS. Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia. Eur J Haematol 1998; 60: 267-8.
9. Mollapour E, Porter JB, Kacmarski R, Linch D, Roberts PJ. Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease. Blood 1998; 91: 3423-9.
10. Davies SC, Olatunji PO. Blood transfusion in sickle cell disease. Vox Sang 1995; 68: 145-51.
11. Emond AM, Morias P, Venugopal S, Carpenter RG, Serjeant GR. Role of splenectomy in homozygous sickle cell disease in childhood. Lancet 1984; i: 88-90.
12. Serjeant GR. Sickle Cell Disease. Oxford: Oxford University Press, 1992.
13. Rogers DW, Clarke JM, Cepidore L et al. Early deaths in Jamaican children with sickle cell disease. BMJ1978; 1: 1515-16.
14. Brown KE, Young NS. Parvovirus B19 infection and haematopoiesis. Blood Rev 1995; 9: 176-82.
15. Megas H, Papdaki E, Constantinides B. Salmonella septicaemia and aplastic crisis in a patient with sickle cell anaemia. Acta Pediatr 1961; 50: 517-21.
16. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114-17.
17. Virag R, Bachir D, Lee K, Galacteros F. Preventive treatment of priapism in sickle cell disease with oral and selfadministered intracavernous injection of etilefrine. Urology 1996; 47: 777-81.
18. Mantadakis E, Ewalt DH, Cavender JD et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anaemia and prolonged priapism. Blood 2000; 95: 78-82.
19. Fowler JE Jr, Koshy M, Strub M, Chin SK. Priapism associated with the sickle haemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991; 145: 65-8.
20. Okpala IE, Westerdale N, Jegede T, Cheung B. Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol 2002; 118: 918-21.
21. Ihekwaba FN. Priapism in sickle cell anaemia. J R Coll Surg Edinb 1980; 25: 133.
22. Winter CC. Priapism cured by creation of fistulas between glans penis and corpora cavernosa. J Urol 1978; 119: 227-8.
23. Gbadoe AD, Atakouma Y, Kusiaku K, Assimadi JK. Management of sickle cell priapism with etilefrine. Arch Dis Child 2001; 85: 52-3.
24. Bachir D, Galacteros E, Lee K, Virag R. Two years experience in management of priapism and impotence in sickle cell disease. Blood 1996; 88 (Suppl): 14a.
25. Steinberg MH, Rodgers GP. Pathophysiology of sickle cell disease: role of genetic and cellular modifiers. Semin Hematol 2001; 38: 229-306.
26. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease - life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-43.
27. Okpala IE, Daniel Y, Haynes R, Odoemene D, Goldman JM. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol 2002; 69: 135-44.
28. Herard A, Colin J, Youinou Y, Drancourt E, Brandt B. Massive hematuria in a sickle cell trait patient with renal papillary necrosis. Eur Urol 1998; 34: 161-2.
29. Ataga KI, Orringer EU. Renal abnormalities in sickle cell disease. Am J Hematol 2000; 63: 205-11.
30. Kark JA, Posey DM, Schumacher HR Jr, Ruehle CJ. Sickle cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987; 317: 781-7.
31. Essien EM. Platelets and platelet disorders in Africa (review). Baillieres Clin Haematol 1992; 5: 441-56.